Novartis AG Adjustments For Decrease Increase In Trade Account Receivable
Novartis AG (NVS) reported Adjustments For Decrease Increase In Trade Account Receivable of -$1.12 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes › Receivables
ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable · last filed 2026-02-04
- Novartis AG adjustments for decrease increase in trade account receivable for the quarter ending 2025-06-30 was -$167.00M.
- Novartis AG adjustments for decrease increase in trade account receivable for the quarter ending 2024-06-30 was -$501.00M.
- Novartis AG adjustments for decrease increase in trade account receivable for the quarter ending 2023-06-30 was -$447.00M.
- Novartis AG adjustments for decrease increase in trade account receivable for the quarter ending 2022-06-30 was -$413.00M.
| Period end | Adjustments For Decrease Increase In Trade Account Receivable 3 month | Adjustments For Decrease Increase In Trade Account Receivable 3 month as first filed | Adjustments For Decrease Increase In Trade Account Receivable 6 month | Adjustments For Decrease Increase In Trade Account Receivable 6 month as first filed | Adjustments For Decrease Increase In Trade Account Receivable 12 month | Adjustments For Decrease Increase In Trade Account Receivable 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | -$1.12B 20-F · filed 2026-02-04 | |||||
| 2025-06-30 | -$167.00M 6-K · filed 2025-07-17 | -$1.21B 6-K · filed 2025-07-17 | ||||
| 2024-12-31 | -$931.00M 20-F · filed 2026-02-04 | |||||
| 2024-06-30 | -$501.00M 6-K · filed 2025-07-17 | -$1.42B 6-K · filed 2025-07-17 | ||||
| 2023-12-31 | -$1.50B 20-F · filed 2026-02-04 | |||||
| 2023-06-30 | -$447.00M 6-K · filed 2024-07-18 | -$425.00M 6-K · filed 2023-07-18 | -$1.15B 6-K · filed 2024-07-18 | -$1.27B 6-K · filed 2023-07-18 | ||
| 2022-12-31 | -$397.00M 20-F · filed 2025-01-31 | -$589.00M 20-F · filed 2023-02-01 | ||||
| 2022-06-30 | -$413.00M 6-K · filed 2023-07-18 | -$909.00M 6-K · filed 2023-07-18 | ||||
| 2021-12-31 | -$352.00M 20-F · filed 2024-01-31 | -$389.00M 20-F · filed 2022-02-02 | ||||
| 2020-12-31 | $137.00M 20-F/A · filed 2023-05-15 | |||||
| 2019-12-31 | -$980.00M 20-F · filed 2022-02-02 | |||||
| 2018-12-31 | -$544.00M 20-F · filed 2021-01-26 | -$569.00M 20-F · filed 2019-01-30 | ||||
| 2017-12-31 | -$655.00M 20-F · filed 2020-01-29 | -$204.00M 6-K · filed 2018-01-24 | ||||
| 2016-12-31 | -$229.00M 20-F · filed 2019-01-30 | |||||
| 2015-12-31 | -$513.00M 6-K · filed 2018-01-24 |